DHODH
Dihydroorotate dehydrogenase (quinone), mitochondrial
Also known as: PYRD_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q02127
- Gene
- DHODH
- Ensembl
- ENSG00000102967
- Chromosome
- 16
- Canonical length
- 395 aa
- Protein class
- Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins
- Subcellular location
- Nucleoplasm,Mitochondria,Cytosol
OverviewNCBI Gene
The protein encoded by this gene catalyzes the fourth enzymatic step, the ubiquinone-mediated oxidation of dihydroorotate to orotate, in de novo pyrimidine biosynthesis. This protein is a mitochondrial protein located on the outer surface of the inner mitochondrial membrane. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
395 residues, UniProt reviewed canonical sequence.
>Q02127|DHODH
1 MAWRHLKKRA QDAVIILGGG GLLFASYLMA TGDERFYAEH LMPTLQGLLD PESAHRLAVR
61 FTSLGLLPRA RFQDSDMLEV RVLGHKFRNP VGIAAGFDKH GEAVDGLYKM GFGFVEIGSV
121 TPKPQEGNPR PRVFRLPEDQ AVINRYGFNS HGLSVVEHRL RARQQKQAKL TEDGLPLGVN
181 LGKNKTSVDA AEDYAEGVRV LGPLADYLVV NVSSPNTAGL RSLQGKAELR RLLTKVLQER
241 DGLRRVHRPA VLVKIAPDLT SQDKEDIASV VKELGIDGLI VTNTTVSRPA GLQGALRSET
301 GGLSGKPLRD LSTQTIREMY ALTQGRVPII GVGGVSSGQD ALEKIRAGAS LVQLYTALTF
361 WGPPVVGKVK RELEALLKEQ GFGGVTDAIG ADHRRLocalizationUniProt · AlphaFold · HPA
Whether an antibody against DHODH can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.23
- Highest tissue expression
- 59 nTPM
Expression across tissuesHPA
Tissue
- liver: 59 nTPM
- skeletal muscle: 9.4 nTPM
- tongue: 7.5 nTPM
- heart muscle: 7.4 nTPM
- kidney: 7.4 nTPM
- adipose tissue: 6.9 nTPM
Single-cell type
- epicardial cells: 164 nCPM
- hepatocytes: 148 nCPM
- cardiomyocytes: 42 nCPM
- oocytes: 32 nCPM
- lymphatic endothelial cells: 27 nCPM
- tuft cells: 23 nCPM
Immune cell
- myeloid DC: 15 nTPM
- plasmacytoid DC: 14 nTPM
- MAIT T-cell: 13 nTPM
- naive CD8 T-cell: 13 nTPM
- memory B-cell: 12 nTPM
- naive B-cell: 12 nTPM
Brain region
- white matter: 14 nTPM
- cerebral cortex: 13 nTPM
- cerebellum: 12 nTPM
- choroid plexus: 12 nTPM
- basal ganglia: 12 nTPM
- medulla oblongata: 11 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about DHODH.
Disease | AllUniProt
Conditions DHODH is implicated in, by any mechanism.
- Postaxial acrofacial dysostosis (POADS) MIM:263750
Disease | GeneticClinVar
13 pathogenic / likely-pathogenic of 217 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Miller syndrome
- DHODH-related disorder
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.78
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.34
- DepMap mean gene effect
- -0.36
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- 'de novo' pyrimidine nucleobase biosynthetic process
- 'de novo' UMP biosynthetic process
- pyrimidine ribonucleotide biosynthetic process
- UDP biosynthetic process
Molecular functions
- dihydroorotase activity
- dihydroorotate dehydrogenase (quinone) activity
- dihydroorotate dehydrogenase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Dihydroorotate dehydrogenase, catalytic
- Aldolase-type TIM barrel
- Dihydroorotate dehydrogenase
- Dihydroorotate dehydrogenase, conserved site
- Dihydroorotate dehydrogenase, class 2
- Dihydroorotate dehydrogenase
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads DHODH as an antibody target. Whether an autoantibody or antibody against DHODH could matter depends on whether native DHODH is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
DHODH is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label DHODH as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...